Apart from these low-frequency genes, we included a set of known cancer genes (IDH1, IDH2, PTEN, TP53, NOTCH1, EGFR, CDKN2A, CDKN2B, NF1 and PIK3R1) for reference on our targeted resequencing effort. The gene discussed is IDH2; the disease is cancer.